CASPIAN CAPITAL LP Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001518999
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2025 · 11 positions · Total reported value $151.21M · Top-10 concentration 100.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 56.2% · 3 new · 4 cut · 2 exited
Active Share (vs S&P 500): 99.7% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -14.4% · vs SPY -16.5% · Prev Value $176.13M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -4.0% · vs SPY -6.2% · Latest Value $237.29M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q4 2025 13F filing, CASPIAN CAPITAL LP disclosed 11 equity positions with a combined reported value of $151.21M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Industrials Tilt / High Turnover.
The largest disclosed positions as of Q4 2025 were BLCO ($34.14M), FIP ($24.02M), FTAI ($21.94M). By sector, the heaviest allocations are Industrials 38.6%, Health Care 32.3%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+19.5pp) and away from Health Care (-2.4pp), Industrials (-17.1pp).
Versus the prior quarter, CASPIAN CAPITAL LP opened 3 new positions, trimmed 4 and fully exited 2, a turnover rate of 56.2% of positions. The portfolio's overlap with the prior quarter was 33% of names.
The largest new positions opened in Q4 2025 were FTAI ($21.94M), CCO ($20.50M), PACS ($14.63M).
Of the 2 positions fully exited versus the prior quarter, the largest were MD ($12.92M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2025)
Fully Exited (vs previous quarter)
- MD PEDIATRIX MEDICAL GROUP INC · prev qtr: $12.92M
Insider Transactions (Form 4)
Latest CASPIAN CAPITAL LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Caspian Capital, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 13 positions worth $176.13M in total. HoldingsHub carries 4 quarters of its filings (Q3 2024–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-72238 (status: Approved), registered 2011-04-07
- Regulatory AUM (Form ADV): $7.03B as of 2026-03-31
- Client mix (by RAUM): pension and profit-sharing plans 94%, registered investment companies 6%
- Manages 10 private funds, of which 9 hedge funds
Portfolio Structure
- 13 positions · $176.13M reported value (Q2 2026)
- Top 10 holdings = 96.5% of reported value
- Largest position: HYG (ISHARES IBOXX $ HIGH YIELD CORPORATE BOND ETF) at 22.7%
- Average position size: $13.55M
Sector Tilt
- Industrials 42.3%
- Health Care 18.8%
- Consumer Discretionary 7.6%
- (classified holdings cover 72% of value)
Quarterly Activity
- Q2 2026: 4 new, 2 added, 1 reduced
- 6 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
2.00M | $34.14M | 22.58% | Add | |
| 2 |
|
5.21M | $24.02M | 15.89% | Add | |
| 3 |
|
111.44K | $21.94M | 14.51% | New | |
| 4 |
|
9.28M | $20.50M | 13.56% | New | |
| 5 |
|
381.19K | $14.63M | 9.68% | New | |
| 6 |
|
227.72K | $12.35M | 8.17% | New | |
| 7 |
|
250.00K | $10.69M | 7.07% | New | |
| 8 |
|
728.31K | $4.99M | 3.30% | Reduce | |
| 9 |
|
276.23K | $4.24M | 2.80% | New | |
| 10 |
|
450.36K | $3.71M | 2.45% | New | |
| 11 |
|
50.00K | $1.95K | 0.00% | Hold | |
FAQ
What did CASPIAN CAPITAL LP buy in 2025-Q4?
In its 2025-Q4 13F filing, CASPIAN CAPITAL LP reported 11 equity positions worth $151.21M in aggregate; its largest disclosed positions were BLCO ($34.14M), FIP ($24.02M), FTAI ($21.94M).
How large is CASPIAN CAPITAL LP's portfolio?
CASPIAN CAPITAL LP reported $151.21M of long equity holdings across 11 positions as of 2025-Q4. Top-10 holdings account for 100.0% of reported value.
What is CASPIAN CAPITAL LP's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Industrials Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.